NOVARTIS AG-SPONSORED ADR (NVS) Fundamental Analysis & Valuation
NYSE:NVS • US66987V1098
Current stock price
142.94 USD
-2.56 (-1.76%)
At close:
142.94 USD
0 (0%)
After Hours:
This NVS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. NVS Profitability Analysis
1.1 Basic Checks
- NVS had positive earnings in the past year.
- NVS had a positive operating cash flow in the past year.
- Each year in the past 5 years NVS has been profitable.
- NVS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- NVS has a Return On Assets of 12.60%. This is amongst the best in the industry. NVS outperforms 93.19% of its industry peers.
- With an excellent Return On Equity value of 30.31%, NVS belongs to the best of the industry, outperforming 93.19% of the companies in the same industry.
- NVS has a Return On Invested Capital of 19.32%. This is amongst the best in the industry. NVS outperforms 95.81% of its industry peers.
- NVS had an Average Return On Invested Capital over the past 3 years of 17.15%. This is above the industry average of 13.10%.
- The last Return On Invested Capital (19.32%) for NVS is above the 3 year average (17.15%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.6% | ||
| ROE | 30.31% | ||
| ROIC | 19.32% |
ROA(3y)13.05%
ROA(5y)12.66%
ROE(3y)29.75%
ROE(5y)27.29%
ROIC(3y)17.15%
ROIC(5y)14%
1.3 Margins
- NVS's Profit Margin of 24.83% is amongst the best of the industry. NVS outperforms 92.67% of its industry peers.
- NVS's Profit Margin has improved in the last couple of years.
- Looking at the Operating Margin, with a value of 33.18%, NVS belongs to the top of the industry, outperforming 95.81% of the companies in the same industry.
- In the last couple of years the Operating Margin of NVS has grown nicely.
- With an excellent Gross Margin value of 75.82%, NVS belongs to the best of the industry, outperforming 83.25% of the companies in the same industry.
- In the last couple of years the Gross Margin of NVS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 33.18% | ||
| PM (TTM) | 24.83% | ||
| GM | 75.82% |
OM growth 3Y12.14%
OM growth 5Y6.09%
PM growth 3Y15.69%
PM growth 5Y8.94%
GM growth 3Y0.74%
GM growth 5Y1.28%
2. NVS Health Analysis
2.1 Basic Checks
- NVS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- The number of shares outstanding for NVS has been reduced compared to 1 year ago.
- Compared to 5 years ago, NVS has less shares outstanding
- The debt/assets ratio for NVS is higher compared to a year ago.
2.2 Solvency
- NVS has an Altman-Z score of 4.26. This indicates that NVS is financially healthy and has little risk of bankruptcy at the moment.
- With a decent Altman-Z score value of 4.26, NVS is doing good in the industry, outperforming 70.16% of the companies in the same industry.
- The Debt to FCF ratio of NVS is 2.32, which is a good value as it means it would take NVS, 2.32 years of fcf income to pay off all of its debts.
- NVS has a better Debt to FCF ratio (2.32) than 94.24% of its industry peers.
- A Debt/Equity ratio of 0.64 indicates that NVS is somewhat dependend on debt financing.
- NVS's Debt to Equity ratio of 0.64 is on the low side compared to the rest of the industry. NVS is outperformed by 71.20% of its industry peers.
- Even though the debt/equity ratio score it not favorable for NVS, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.64 | ||
| Debt/FCF | 2.32 | ||
| Altman-Z | 4.26 |
ROIC/WACC4.08
WACC4.73%
2.3 Liquidity
- A Current Ratio of 1.12 indicates that NVS should not have too much problems paying its short term obligations.
- Looking at the Current ratio, with a value of 1.12, NVS is doing worse than 84.29% of the companies in the same industry.
- A Quick Ratio of 0.89 indicates that NVS may have some problems paying its short term obligations.
- With a Quick ratio value of 0.89, NVS is not doing good in the industry: 82.72% of the companies in the same industry are doing better.
- NVS does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.12 | ||
| Quick Ratio | 0.89 |
3. NVS Growth Analysis
3.1 Past
- The Earnings Per Share has been growing slightly by 4.83% over the past year.
- Measured over the past years, NVS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 9.21% on average per year.
- NVS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.91%.
- NVS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.45% yearly.
EPS 1Y (TTM)4.83%
EPS 3Y13.63%
EPS 5Y9.21%
EPS Q2Q%-12.72%
Revenue 1Y (TTM)8.91%
Revenue growth 3Y9.1%
Revenue growth 5Y2.45%
Sales Q2Q%-0.91%
3.2 Future
- The Earnings Per Share is expected to grow by 7.49% on average over the next years.
- The Revenue is expected to grow by 5.35% on average over the next years.
EPS Next Y-0.14%
EPS Next 2Y4.63%
EPS Next 3Y6.15%
EPS Next 5Y7.49%
Revenue Next Year2.49%
Revenue Next 2Y3.87%
Revenue Next 3Y4.58%
Revenue Next 5Y5.35%
3.3 Evolution
- The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. NVS Valuation Analysis
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 16.35 indicates a correct valuation of NVS.
- Based on the Price/Earnings ratio, NVS is valued cheaply inside the industry as 85.34% of the companies are valued more expensively.
- NVS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.54.
- A Price/Forward Earnings ratio of 14.46 indicates a correct valuation of NVS.
- Based on the Price/Forward Earnings ratio, NVS is valued cheaper than 82.72% of the companies in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 21.68, NVS is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.35 | ||
| Fwd PE | 14.46 |
4.2 Price Multiples
- NVS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. NVS is cheaper than 84.29% of the companies in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of NVS indicates a rather cheap valuation: NVS is cheaper than 84.82% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.99 | ||
| EV/EBITDA | 12.61 |
4.3 Compensation for Growth
- The excellent profitability rating of NVS may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.78
EPS Next 2Y4.63%
EPS Next 3Y6.15%
5. NVS Dividend Analysis
5.1 Amount
- NVS has a Yearly Dividend Yield of 3.23%.
- Compared to an average industry Dividend Yield of 0.73, NVS pays a better dividend. On top of this NVS pays more dividend than 94.24% of the companies listed in the same industry.
- NVS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.23% |
5.2 History
- The dividend of NVS has a limited annual growth rate of 5.38%.
- NVS has paid a dividend for at least 10 years, which is a reliable track record.
- NVS has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)5.38%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
- 55.91% of the earnings are spent on dividend by NVS. This is a bit on the high side, but may be sustainable.
- The dividend of NVS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP55.91%
EPS Next 2Y4.63%
EPS Next 3Y6.15%
NVS Fundamentals: All Metrics, Ratios and Statistics
142.94
-2.56 (-1.76%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Industry StrengthN/A
Industry GrowthN/A
Earnings (Last)04-28 2026-04-28/bmo
Earnings (Next)07-21 2026-07-21
Inst Owners43.85%
Inst Owner Change-3.59%
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap274.27B
Revenue(TTM)56.33B
Net Income(TTM)13.98B
Analysts70.59
Price Target159.48 (11.57%)
Short Float %0.34%
Short Ratio2.74
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.23% |
Yearly Dividend4.02
Dividend Growth(5Y)5.38%
DP55.91%
Div Incr Years6
Div Non Decr Years6
Ex-Date03-11 2026-03-11 (4.740247)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1.14%
Min EPS beat(2)-2.1%
Max EPS beat(2)-0.17%
EPS beat(4)2
Avg EPS beat(4)1.23%
Min EPS beat(4)-2.1%
Max EPS beat(4)6.59%
EPS beat(8)6
Avg EPS beat(8)2.93%
EPS beat(12)9
Avg EPS beat(12)2.91%
EPS beat(16)11
Avg EPS beat(16)2.66%
Revenue beat(2)0
Avg Revenue beat(2)-3.85%
Min Revenue beat(2)-4.89%
Max Revenue beat(2)-2.82%
Revenue beat(4)0
Avg Revenue beat(4)-2.92%
Min Revenue beat(4)-4.89%
Max Revenue beat(4)-1.13%
Revenue beat(8)2
Avg Revenue beat(8)-1.5%
Revenue beat(12)3
Avg Revenue beat(12)-2.67%
Revenue beat(16)4
Avg Revenue beat(16)-0.2%
PT rev (1m)4.64%
PT rev (3m)20.87%
EPS NQ rev (1m)1.12%
EPS NQ rev (3m)-4.85%
EPS NY rev (1m)-0.83%
EPS NY rev (3m)-4.4%
Revenue NQ rev (1m)0.69%
Revenue NQ rev (3m)-0.55%
Revenue NY rev (1m)-0.26%
Revenue NY rev (3m)-0.21%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.35 | ||
| Fwd PE | 14.46 | ||
| P/S | 4.87 | ||
| P/FCF | 17.99 | ||
| P/OCF | 14.33 | ||
| P/B | 5.95 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.61 |
EPS(TTM)8.74
EY6.11%
EPS(NY)9.88
Fwd EY6.91%
FCF(TTM)7.94
FCFY5.56%
OCF(TTM)9.98
OCFY6.98%
SpS29.36
BVpS24.04
TBVpS-4.61
PEG (NY)N/A
PEG (5Y)1.78
Graham Number68.7582 (-51.9%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.6% | ||
| ROE | 30.31% | ||
| ROCE | 22.34% | ||
| ROIC | 19.32% | ||
| ROICexc | 22.42% | ||
| ROICexgc | 94.51% | ||
| OM | 33.18% | ||
| PM (TTM) | 24.83% | ||
| GM | 75.82% | ||
| FCFM | 27.06% |
ROA(3y)13.05%
ROA(5y)12.66%
ROE(3y)29.75%
ROE(5y)27.29%
ROIC(3y)17.15%
ROIC(5y)14%
ROICexc(3y)20.47%
ROICexc(5y)17.14%
ROICexgc(3y)94.66%
ROICexgc(5y)84.88%
ROCE(3y)20.57%
ROCE(5y)16.8%
ROICexgc growth 3Y10.97%
ROICexgc growth 5Y16.26%
ROICexc growth 3Y23.26%
ROICexc growth 5Y13.82%
OM growth 3Y12.14%
OM growth 5Y6.09%
PM growth 3Y15.69%
PM growth 5Y8.94%
GM growth 3Y0.74%
GM growth 5Y1.28%
F-Score8
Asset Turnover0.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.64 | ||
| Debt/FCF | 2.32 | ||
| Debt/EBITDA | 1.23 | ||
| Cap/Depr | 73.24% | ||
| Cap/Sales | 6.92% | ||
| Interest Coverage | 19.05 | ||
| Cash Conversion | 79.71% | ||
| Profit Quality | 109.01% | ||
| Current Ratio | 1.12 | ||
| Quick Ratio | 0.89 | ||
| Altman-Z | 4.26 |
F-Score8
WACC4.73%
ROIC/WACC4.08
Cap/Depr(3y)63.14%
Cap/Depr(5y)55.05%
Cap/Sales(3y)6.73%
Cap/Sales(5y)6.62%
Profit Quality(3y)101.15%
Profit Quality(5y)104.02%
High Growth Momentum
Growth
EPS 1Y (TTM)4.83%
EPS 3Y13.63%
EPS 5Y9.21%
EPS Q2Q%-12.72%
EPS Next Y-0.14%
EPS Next 2Y4.63%
EPS Next 3Y6.15%
EPS Next 5Y7.49%
Revenue 1Y (TTM)8.91%
Revenue growth 3Y9.1%
Revenue growth 5Y2.45%
Sales Q2Q%-0.91%
Revenue Next Year2.49%
Revenue Next 2Y3.87%
Revenue Next 3Y4.58%
Revenue Next 5Y5.35%
EBIT growth 1Y14.46%
EBIT growth 3Y22.35%
EBIT growth 5Y8.7%
EBIT Next Year12.61%
EBIT Next 3Y8.86%
EBIT Next 5Y9.84%
FCF growth 1Y10.42%
FCF growth 3Y9.64%
FCF growth 5Y6.62%
OCF growth 1Y8.66%
OCF growth 3Y10.38%
OCF growth 5Y7%
NOVARTIS AG-SPONSORED ADR / NVS Fundamental Analysis FAQ
What is the ChartMill fundamental rating of NOVARTIS AG-SPONSORED ADR (NVS) stock?
ChartMill assigns a fundamental rating of 7 / 10 to NVS.
What is the valuation status for NVS stock?
ChartMill assigns a valuation rating of 6 / 10 to NOVARTIS AG-SPONSORED ADR (NVS). This can be considered as Fairly Valued.
Can you provide the profitability details for NOVARTIS AG-SPONSORED ADR?
NOVARTIS AG-SPONSORED ADR (NVS) has a profitability rating of 9 / 10.
What is the financial health of NOVARTIS AG-SPONSORED ADR (NVS) stock?
The financial health rating of NOVARTIS AG-SPONSORED ADR (NVS) is 7 / 10.
Can you provide the expected EPS growth for NVS stock?
The Earnings per Share (EPS) of NOVARTIS AG-SPONSORED ADR (NVS) is expected to decline by -0.14% in the next year.